First Subjects Enrolled in Epigenomics Sponsored PRESEPT Colorectal Cancer Screening Study
June 30, 2008 03:07 ET
|
Epigenomics AG
SEATTLE and BERLIN, June 30, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer detection...
Epigenomics Successfully Completes Larger Clinical Study in Early Lung Cancer Detection
June 18, 2008 03:12 ET
|
Epigenomics AG
BERLIN and SEATTLE, June 18, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer detection...
Epigenomics Successfully Completes Clinical Study in Lung Cancer Diagnosis
June 09, 2008 02:38 ET
|
Epigenomics AG
BERLIN and SEATTLE, June 9, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer based on...
Epigenomics AG Reports First Quarter 2008 Financial Results
May 06, 2008 02:55 ET
|
Epigenomics AG
Key Figures
-- Revenue: EUR 0.9 million in Q1 2008, up by 12% (Q1 2007: EUR 0.8
million)
-- EBIT: EUR -3.0 million in Q1 2008, improved by 13% (Q1 2007: EUR
-3.4 million)
-- Net loss:...
Epigenomics AG Successfully Validates Optimized Blood-Based Colorectal Cancer Assay in Two Independent Clinical Studies
April 21, 2008 02:17 ET
|
Epigenomics AG
BERLIN and SEATTLE, April 21, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer based on...
Epigenomics AG Presents Data on Novel Prostate Cancer Biomarkers at AACR
April 14, 2008 02:41 ET
|
Epigenomics AG
BERLIN and SEATTLE, April 14, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt Prime Standard: ECX), a molecular diagnostics company focusing on the development and commercialization of in-vitro...
Epigenomics and TIB MOLBIOL Launch First in a Series of Products At Analytica 2008
April 01, 2008 03:15 ET
|
Epigenomics AG
BERLIN and SEATTLE, April 1, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECS) (Prime Standard), a molecular diagnostics company developing products based on DNA methylation analysis, together...
Epigenomics AG Reports Financial Results for a Successful Fiscal Year 2007
March 31, 2008 02:18 ET
|
Epigenomics AG
Successful execution on corporate strategy - Financial and strategic
framework set for the future
Financials in line with latest expectations:
-- Full year revenue EUR 2.6 million
--...
Announcement acc. to Sections 37v-x WpHG: Epigenomics AG: Announcement According to Sections 37v, 37w, 37x, 37y WpHG With the Aim of European-Wide Distribution
March 13, 2008 10:54 ET
|
Epigenomics AG
BERLIN, March 13, 2008 (PRIME NEWSWIRE) -- Advance announcement on the disclosure of financial statements by Epigenomics AG.
Epigenomics AG hereby announces that in the fiscal year 2008 the...
Epigenomics AG to Host Press Conference and Analyst Meeting for 2007 Annual Results
March 13, 2008 07:23 ET
|
Epigenomics AG
BERLIN, Germany and SEATTLE, March 13, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a cancer molecular diagnostics company, will hold its annual press conference and analyst meeting on...